Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 286
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
PT234 – Christopher Solomon – Salvia as a Therapist
Better Plant Appoints Branding Expert Perry Chua as Chief Creative Officer
COMPASS Pathways plc announces financial results and business highlights for fourth...
Psychedelics Research Review: February 2021
NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug...
MINDCURE Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research...
MindMed Announces C$19.5 Million Bought Deal Private Placement Offering
Psychedelic Speech: How Drugs Disorganize Normal Communication Patterns
Cybin Inc. Shares Commence Trading on the OTCQB Venture Market on...
Silo Wellness Kicks Off Second Oregon Psychedelic Wellness Retreat
Load more